Coda Octopus Group, Inc. has appointed Mark Kelly as its new Chief Financial Officer (CFO). The appointment is effective August 3, 2026, and is subject to a three-month probationary period that may be extended. Gayle Jardine, the current Interim CFO, will retire on August 3, 2026. Mark Kelly's prior experience includes roles as Finance Director at Medac Pharma, Head of Glasgow Finance at Chubb Insurance, Finance Director at Twist Bioscience Corp., and Senior Finance Director/European Controller at Charles River Laboratories. He qualified as a Chartered Accountant in 1996 and holds a BA Honours in Accounting and Finance from the University of Strathclyde. Mr. Kelly will receive an annual base salary of £165,000 (approximately $218,625). He is eligible for discretionary annual bonuses and will receive a restricted stock grant valued at $40,000, vesting in two equal annual installments starting October 31, 2027, contingent on performance milestones.